[ primary packshot ]
Precision pen on Lab White
[detail]
[scale]
[360°]
[lab]
RECOVERY & REPAIR

ZENCOVER

BPC-157 + TB-500

240 units · 3 mL pen↓ Testing

A two-peptide combination of BPC-157 (Body Protection Compound-157) and TB-500 (a Thymosin Beta-4 fragment), synthesized to a written specification and verified at the molecular level before listing. Studied in connective-tissue recovery models.

Ships FREE from within Canada · No customs · no border delays.

$848.00CAD

OVERVIEW

Two repair peptides studied in connective-tissue models.

ZENCOVER blends BPC-157, a synthetic peptide fragment studied in tissue-repair models, with TB-500, a synthetic fragment of Thymosin Beta-4 studied in cell-migration and repair research. The combination is studied in connective-tissue recovery contexts.

Research interest centres on angiogenesis modulation and cytoskeletal / cell-migration signalling, mediated through local and paracrine rather than systemic pathways.

ZENCOVER is a research-grade formulation, not an authorized medicine, and Zenovate makes no claim about its effects in humans. Every batch is synthesized to a written specification and tested for identity, purity and stability by an independent accredited laboratory before it is listed.

SPECIFICATIONS

ClassTissue-repair signalling peptides
Molecular weight[molecular weight]
Verified purityTested by UPLC / HPLC
FormatPrecision pen · 240u / 3 mL
Storage2–8°C, protect from light
Pen strengthBPC-157 3.33 + TB-500 3.33 mg/mL · 20 mg
Laboratory[Independent accredited lab]

THE RESEARCH

Cited research areas: angiogenesis modulation; cytoskeletal and cell-migration pathways; peptide stability and formulation chemistry.

Aleksiev et al., J. Orthopedic Research (2019)Smith et al., Peptide Therapeutics Review (2020)

We cite the literature. We make no claims about effects or outcomes, and no comparison to prescription products.

[ testing methods ]
Identity · purity · stability

TESTING & QUALITY ASSURANCE

Every batch is tested before it ships.

Identity & purityUPLC / HPLC (PDA)
Mass confirmationLC-MS (ESI)
SequenceLC-MS/MS
Heavy metalsICP-MS
Water contentKarl Fischer titration
StabilityReal-time & accelerated

COMPOUND FAQ

Questions specific to ZENCOVER.

Is ZENCOVER a prescription medicine?

No. ZENCOVER is a research-grade formulation with no marketing authorization in Canada; it is not a medicine and not a substitute for one.

How do I verify what is in a ZENCOVER vial?

Every batch is tested for identity, purity and stability by an independent accredited laboratory using UPLC / HPLC, LC-MS and related methods. Our full testing methodology is published on the Lab Results page.

Why does Zenovate avoid naming prescription brands?

Because comparing a research compound to an authorized medicine would be both misleading and non-compliant; they are different categories held to different standards of evidence.

Compounded products are not evaluated by Health Canada for safety, effectiveness or quality. ZENCOVER is a research-grade formulation, not a medicine, and nothing on this page is medical advice. For adults 19 and older.